Exavir Therapeutics announces the publication of preclinical data for the ultra-long-acting integrase inhibitor XVIR-110 in Nature Communications, affirming its unique pharmacokinetic profile and potential as a best-in-class yearly antiretroviral
08 juin 2021 07h00 HE
|
Exavir Therapeutics
With a single administration, XVIR-110, a nano-formulated prodrug integrase inhibitor, provided year-long plasma drug levels sufficient for HIV treatment and prophylaxis in animal models Studies...
Codex DNA Expands End-to-End Automated Synthetic Biology Workstation Enabling High Throughput Synthesis from DNA Sequence to Biologically Active mRNA
27 avr. 2021 10h00 HE
|
Codex
San Diego, CA, April 27, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the BioXp™ system, a fully automated benchtop instrument that enables numerous synthetic biology workflows, today...
Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial
16 mars 2021 08h30 HE
|
Brain Scientific Inc.
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration...
Milestone Scientific to Present at the Q1 Virtual Investor Summit
12 mars 2021 07h00 HE
|
Milestone Scientific Inc.
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually...
Interpace Biosciences Announces Contract for Thyroid Testing with Blue Cross Blue Shield of Florida
28 janv. 2021 09h15 HE
|
Interpace Biosciences, Inc.
In-network status for ThyGeNEXT® and ThyraMIR® with State’s Largest Payer PARSIPPANY, NJ, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that the...
Cocrystal Pharma Selects Lead Compound for Further Development Against Coronaviruses
22 déc. 2020 08h30 HE
|
Cocrystal Pharma, Inc.
CDI-45205 holds potential as a therapeutic and as a prophylactic to protect against coronavirus transmission, including SARS-CoV-2 BOTHELL, Wash., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cocrystal...
TeneoFour’s CD38 Inhibitor Rejuvenates Energy Metabolism of Aged Animals
16 nov. 2020 11h00 HE
|
TeneoBio, Inc
NEWARK, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Teneobio, Inc. and its affiliate TeneoFour, Inc. announced today a Nature Metabolism publication...
BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger
30 juil. 2020 07h30 HE
|
BetterLife Pharma
Vancouver, July 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary...
BetterLife CEO Discusses Synairgen’s Interferon Breakthrough Treatment
28 juil. 2020 08h00 HE
|
BetterLife Pharma
New York City, July 28, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing a potential...
BetterLife CEO Discusses Merger, Planned Interferon Treatment Trials and Potential Subsequent FDA Emergency Use Authorization
23 juil. 2020 08h00 HE
|
BetterLife Pharma
New York City, July 23, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRD) (CSE:BETR), an emerging biotechnology company currently preparing its own...